The Register and the Shelf: Checking CBD Novel Food Status in the UK in 2026

At Cannabi CBD, the question we hear most often about CBD regulation is not whether an oil is strong, but whether the bottle in front of the shopper is legally on the shelf. That is a paperwork question before it is a product question. In the UK, ingestible CBD sits within the novel food regime, and the register that supports that regime is often read as a simple pass-or-fail list. It is not.

What ‘novel food’ means in practice

A novel food is, broadly, a food or food ingredient that was not used for human consumption to a significant degree in the UK or EU before 15 May 1997. CBD extracts used in oils, capsules, gummies and drinks are treated as novel foods. That does not make them medicines, and it does not make them automatically unlawful in every context. It means that, before a food business places them on the market, the product must either be authorised through the novel food process or fall within an arrangement that allows continued sale while an application is assessed.

In Great Britain, the Food Standards Agency administers that process under assimilated Regulation (EU) 2015/2283. Northern Ireland continues to apply the EU novel food regime under separate arrangements. For a UK shopper, the practical point is simpler: novel food status is about the paperwork behind a food product, not about cosmetics, vaping liquids or other categories that sit under different rules.

What the FSA register is — and is not

The FSA publishes a register of CBD products that are linked to novel food applications. The register is a useful public tool, but it is not a seal of approval. Inclusion generally indicates that a product has been linked to an application that the FSA has accepted into the process. It does not mean the product has completed authorisation. It is not a finding that the product is safe, effective or compliant with every labelling rule. Nor is it a purity certificate or a guarantee that a particular batch matches the sample described in an application.

This distinction matters because shoppers sometimes treat the register as a licence. A brand may appear, but the entry may cover a specific product name, format and strength. A brand name alone is not a blanket approval for every oil, capsule or gummy sold under that name. The exact product matters.

Why some products remain on shelves

A product without a valid link to the novel food process is not permitted to be sold as a food. In practice, enforcement is not centralised. Local authority trading standards teams decide how to prioritise checks, and their resources are limited. Some products may remain on shelves because a retailer believes an application covers them; because a register entry is out of date; because stock predates a change; or because the product is a white-label item whose paperwork has not kept pace with the label.

A presence on a shelf is therefore not proof of compliance. Equally, an absent entry is not proof that a product is adulterated. It may simply lack the right paperwork. The calm conclusion is that the register is a map of the application landscape, not a guarantee of legality for every item on every shelf.

A practical check before buying

Start with the exact product, not the brand. Note the product name, format, strength, flavour and any batch or best-before information. Then search the FSA’s CBD novel food register for that exact combination. If only the brand appears, do not assume the item in your hand is covered. Check the date of the entry and whether the product is still listed.

Look for a UK responsible food business on the label, with a postal address. That is a basic accountability check, not a compliance certificate. Ask the retailer, in writing if possible, which application the product is linked to and whether they can point to the register entry. A confident retailer should be able to answer without relying on a QR code to a laboratory certificate. Lab tests can be useful, but they do not establish novel food status. The two are different pieces of evidence.

Treat health claims with caution. CBD is not authorised as a medicine, and food supplements may only carry permitted health claims. A product that promises to treat anxiety, insomnia or pain is making a claim that sits outside the food framework. That does not automatically decide the novel food question, but it is a reason to slow down.

Keep a receipt and a screenshot of the product page or shelf label. If a product has been described as authorised or fully approved when it is not, consumer law may be relevant. The Consumer Rights Act 2015 can apply where goods are not as described, but that is separate from whether the sale itself complies with food law.

If something looks wrong

Ask the retailer a direct question first. If the answer is unclear, contact the trading standards service at the relevant local authority, or use the Citizens Advice consumer service for signposting in England and Wales. Keep the packaging and any correspondence. If you have consumed a product and feel unwell, seek medical advice; regulatory concerns and health concerns should be handled separately.

The novel food maze is not a conspiracy. It is a queue of scientific assessment, application paperwork and local enforcement. For shoppers in 2026, the register is most useful as a prompt for better questions: which exact product is listed, what does the entry actually mean, and can the retailer explain the link? A calm answer to those questions is worth more than a confident badge on a bottle.